SIXTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • May 19th, 2026 • Parabilis Medicines, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 19th, 2026 Company Industry JurisdictionTHIS SIXTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 6th day of January, 2026, by and among Parabilis Medicines, Inc. (formerly known as “FOG Pharmaceuticals, Inc.”), a Delaware corporation (the “Company”), each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor” and any Additional Purchaser (as defined in the Purchase Agreement) that becomes a party to this Agreement in accordance with Section 6.9 hereof.
SIXTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • April 2nd, 2026 • Parabilis Medicines, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledApril 2nd, 2026 Company Industry JurisdictionTHIS SIXTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 6th day of January, 2026, by and among Parabilis Medicines, Inc. (formerly known as “FOG Pharmaceuticals, Inc.”), a Delaware corporation (the “Company”), each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor” and any Additional Purchaser (as defined in the Purchase Agreement) that becomes a party to this Agreement in accordance with Section 6.9 hereof.